Stock Screeners That Start With the Filings
Stock screeners can reduce a market to a shortlist. The useful ones test the business, valuation, and management claims against SEC filings before buying.
A screen that produces 40 cheap stocks has not solved the investor's problem. It has moved the problem downstream. The real work is deciding whether a low multiple reflects a durable business temporarily mispriced by the market, or a business whose economics, balance sheet, or management record deserve skepticism. Useful stock screeners begin that work with evidence, not a ranking designed to look decisive.
For a long-term owner, a screener is not a buy list. It is a method for allocating attention. It should narrow a large universe to companies worth reading about, then make clear which reported figures and assumptions put each company on the list.
What Stock Screeners Should Actually Screen For
Most stock screeners are built for speed. Enter a price-to-earnings ratio, revenue growth rate, market capitalization, or a technical condition, and the tool returns matching tickers. That is convenient, but convenience can create false precision. A company can pass a low P/E filter because earnings are at a cyclical peak. It can show high return on equity because debt has reduced the equity base. It can appear inexpensive on book value while the assets behind that book value are impaired, intangible, or difficult to monetize.
A more useful screen asks whether the figures tell a coherent economic story over time. That means examining a decade of reported revenue, margins, free cash generation, debt, share count, and returns on capital. One strong year is an observation. A durable pattern is evidence.
The distinction matters because valuation is not a contest to find the lowest ratio. It is an attempt to estimate what a business can reasonably earn for its owners through a full cycle. The market price is visible. The value of future cash flows is not. A disciplined screener should acknowledge that uncertainty by presenting a conservative range, not pretending that one calculated fair value is exact.
Start with financial durability
Before considering a price, establish whether the business has the characteristics an owner should want. Screens based on Graham-style quality tests commonly look for adequate earnings stability, a defensible financial position, and a history of shareholder returns. The exact thresholds can vary by industry, but the principle does not: a company should have enough financial resilience to survive an unfavorable period without relying on friendly capital markets.
Debt needs context. A highly leveraged utility may be evaluated differently from a highly leveraged consumer brand. Financial companies require a different framework from manufacturers. Still, a screener should not excuse leverage merely because a company belongs to a leveraged sector. It should show the obligations, the earnings available to service them, and the trend in both.
Cash flow also deserves more scrutiny than a single free-cash-flow yield. Operating cash flow can benefit from working-capital movements that reverse later. Capital expenditure can be postponed. Acquisitions can mask weak organic performance. The screen should help an investor see recurring earning power, not simply the most favorable version of it.
Treat valuation as a range, not a target
An intrinsic-value estimate depends on assumptions about normalized earnings, growth, margins, capital needs, and risk. Reasonable analysts can reach different conclusions without either being careless. That is why margin of safety matters.
Rather than presenting a stock as worth precisely $87.42, a conservative process defines a reasonable value range and then identifies a lower price range where the gap between price and estimated value is substantial enough to absorb mistakes. The wider the uncertainty around the business, the wider that margin should be.
This approach is particularly useful when screening large-cap companies. Familiar businesses can create an illusion of knowability. A widely followed company may have hundreds of analyst estimates and endless commentary, yet its future returns still depend on facts that are not settled: pricing power, capital allocation, competition, regulation, and the quality of reported earnings. Popularity is not a margin of safety.
The Missing Filter: Management Credibility
A financial screen can identify an inexpensive business. It cannot, by itself, tell you whether management's public framing is supported by the company's own disclosures.
Executives speak in earnings calls, investor presentations, television interviews, and prepared remarks. Those venues can be useful, but they reward favorable emphasis. Formal SEC filings are different. They contain the commitments, risks, segment disclosures, accounting policies, related-party transactions, and legal matters a company is required to report.
The gap between these two records is often more informative than a headline. If management repeatedly emphasizes demand strength while filings disclose customer concentration, declining backlog quality, rising warranty claims, or a deteriorating balance-sheet item, the investor has a question worth pursuing. The issue is not that management used optimistic language. Optimism is common. The issue is whether the language leaves out material counterevidence.
A filing-first screener should surface these points as evidence rather than assign a vague sentiment score. The investor needs the executive claim, the relevant disclosure, the date, and the context. That allows independent verification and reduces the risk of treating a software-generated conclusion as a fact.
This is where Hety's approach is deliberately narrow: it compares executive statements with formal filings and identifies inconsistencies or unsupported framing alongside valuation and quality screens. It does not convert those findings into a recommendation. That restraint is appropriate. A governance flag is a reason to investigate, not proof that a stock will fall.
How to Use a Screener Without Outsourcing Judgment
The best workflow is sequential. Screen first for financial quality and a plausible valuation gap. Then read the underlying records. Reversing that order is inefficient when evaluating hundreds or thousands of companies, but stopping after the screen is equally weak.
For every name that survives an initial screen, an investor should be able to answer a few plain questions. What does this company sell, and why do customers continue to buy it? What has driven its earnings across good and bad conditions? How much debt and fixed obligation does it carry? Has management created value through reinvestment, acquisitions, repurchases, or dividends? What could make the conservative valuation case wrong?
The annual report and recent quarterly filings are where many of those answers reside. Read the business description, risk factors, management discussion, debt footnotes, segment data, stock-compensation disclosure, and share-repurchase details. The goal is not to read every page with equal intensity. It is to follow the facts that determine owner earnings and downside risk.
A saved watchlist is useful at this stage. Some companies will be attractive but not cheap enough. Others will be cheap but not understandable enough. Keeping them separate prevents a common error: buying simply because a ticker has remained on a research list for too long. A watchlist records interest. It is not a commitment.
Common Screener Traps
Low valuation multiples are the most obvious trap, but not the only one. Screens can also produce misleading results when they rely on adjusted metrics, exclude dilution, or ignore corporate actions. A company that has reduced its share count through repurchases may appear to have stronger per-share growth, even if the repurchases were financed at an unfavorable price or with additional debt.
Historical performance screens require similar care. Delisted and acquired companies can disappear from databases, creating survivorship bias. Dividends may be excluded from return figures. Spin-offs can make multi-year financial series difficult to compare without restating the history. A credible screener explains these methodological limits rather than hiding them behind a clean chart.
Sector comparisons are another place where judgment matters. A bank, a software company, and a retailer should not be forced through identical measures. Consistency in process does not mean sameness in analysis. It means using a stated criterion, applying it fairly, and explaining why a particular industry requires a different lens.
A Shortlist Is the Beginning of the Work
Stock screeners are valuable when they reduce noise without concealing uncertainty. They should show why a company passed, where it failed, which reported figures matter, and what assumptions support a valuation range. They should leave room for the investor to disagree.
That is the appropriate role of a research tool. It can help a careful owner find the filings worth reading and the claims worth testing. It cannot remove the need to think independently, and it should not try to. Past performance is not predictive of future results, and screened results are not investment advice. The useful next step is simple: take the most interesting name on the list and see whether its filings support the story its market price is telling.
See the best undervalued deals on the market.
You are not going to read the balance sheet. You don’t have three hours per company to do it, and you shouldn’t have to.
Hety runs the value investor checklists you would have to run by hand, now expanded to the NYSE and Nasdaq:
- Intrinsic value range — what the company is actually worth, not what the market says.
- Graham tests — the same criteria Benjamin Graham used to separate real bargains from value traps.
- A filings cross-check — what management claimed on the earnings call, verified against what they actually filed with the SEC.
No stock tips. No “hot picks.” Just the stocks where the price and reality have drifted apart — with the reasoning shown, so you can verify it yourself in minutes not hours.
See this week's most undervalued stocks — freeFree to start · no signup · no card · $29/month for the full list